Medexus Pharmaceuticals (PDDPF) News Today $2.14 0.00 (0.00%) As of 08/4/2023 Add Compare Share Share Headlines Stock AnalysisBuy This Stock PDDPF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Medexus Pharmaceuticals: Channel Headwinds Masking Demand as Strategic Positioning Supports Buy-Rated Risk‑RewardFebruary 16, 2026 | tipranks.comMedexus Pharmaceuticals Inc (MEDXF) Q3 2026 Earnings Call Highlights: Strong Graphopex Demand ...February 13, 2026 | finance.yahoo.comMedexus Pharmaceuticals Inc.: Stable Growth and Promising Outlook Justify Buy RatingNovember 18, 2025 | tipranks.comPositive Growth Outlook for Medexus Pharmaceuticals Inc. Amid Strategic Expansion and Stable PerformanceFebruary 9, 2025 | tipranks.comStifel cuts Medexus Pharma stock rating to Hold, target to C$3.45February 7, 2025 | msn.comMedexus targets $100M annual revenue for GRAFAPEX within 5 years post-launchFebruary 6, 2025 | msn.comEarnings call transcript: Medexus Q3 FY2025 shows revenue growth, FDA approvalFebruary 6, 2025 | msn.comMedexus Pharmaceuticals Inc (MDP) Receives a Buy from Raymond JamesFebruary 3, 2025 | markets.businessinsider.comVentum Financial Reaffirms Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)January 30, 2025 | markets.businessinsider.comMedexus Pharmaceuticals Launches Public Offering to Enhance Financial FlexibilityJanuary 27, 2025 | tipranks.comMedexus Pharma Shares Higher on FDA Approval for GrafapexJanuary 22, 2025 | marketwatch.comMedexus and medac Conclude Negotiations to Amend US Treosulfan Agreement, Setting Regulatory Milestone Amounts and Payment ScheduleDecember 2, 2024 | stockhouse.comMedexus Pharma: Top 10 Undervalued Drug Manufacturers Industry Stocks (MDP)September 2, 2024 | theglobeandmail.comMedexus Pharma:Stocks Analysts Recently Upgraded on TSX (MDP)August 14, 2024 | theglobeandmail.comStifel Nicolaus Reaffirms Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)August 9, 2024 | markets.businessinsider.comClosing Bell: Medexus Pharmaceuticals Inc flat on Monday (MDP)April 3, 2024 | theglobeandmail.comMedexus Pharmaceuticals Inc MEDXFJanuary 10, 2024 | morningstar.comMMedexus Pharmaceuticals Inc MDPDecember 21, 2023 | morningstar.comMMedexus Pharmaceuticals (MEDXF) Price Target Increased by 8.29% to 3.16November 1, 2023 | msn.comClosing Bell: Medexus Pharmaceuticals Inc flat on Tuesday (MDP)October 17, 2023 | theglobeandmail.comMedexus Announces Full Exercise and Closing of Over-Allotment Option in Bought-Deal Public OfferingOctober 17, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Wednesday (MDP-DB)October 12, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc 6.0 Pct Debs flat on Friday (MDP-DB)October 10, 2023 | theglobeandmail.comMedexus Pharmaceuticals announces C$10M offeringSeptember 6, 2023 | msn.comMedexus to Participate in Fireside Chat at SHARE Series EventAugust 4, 2023 | finance.yahoo.comStifel Nicolaus Upgrades Medexus Pharmaceuticals Inc (MDP) to BuyJune 22, 2023 | markets.businessinsider.comMorning News Call - Canada, June 20June 20, 2023 | finance.yahoo.comClosing Bell: Medexus Pharmaceuticals Inc down on Monday (MDP)May 16, 2023 | theglobeandmail.comMedexus gets TSX nod to make NCIB for convertible debenturesMay 10, 2023 | msn.comPharmaceutical Drug Delivery Market Research Findings to 2030May 9, 2023 | marketwatch.comClosing Bell: Medexus Pharmaceuticals Inc down on Friday (MDP)April 22, 2023 | theglobeandmail.comClosing Bell: Medexus Pharmaceuticals Inc up on Monday (MDP)April 11, 2023 | theglobeandmail.comMedexus Pharma Names Michael Mueller Chairman, Forecasts Rise in 4Q RevenueApril 11, 2023 | marketwatch.comMedexus expects FY23 record revenue of $107M-$108MApril 11, 2023 | msn.comDiaphragm Valves for Pharmaceutical Process Market 2023 Key Product Segments, Application Analysis, and Industry Growth Forecast by 2029March 20, 2023 | marketwatch.comDrug and Pharmaceuticals and Cosmetics Retail Market Foreseen To Grow Exponentially Over 2023-2029February 21, 2023 | marketwatch.comAn Overview of Anti-Counterfeit Pharmaceuticals And Cosmetics Market, Major Participants, and Prospects by 2029February 2, 2023 | marketwatch.comMiddle-aged and Elderly Health Supplements Market: 2023 [Latest Report] By Top Leading Players Analysis Till 2028January 31, 2023 | marketwatch.comOral Mucositis Market with Strong Focus on Industry Size, by Financial Highlights, Market Segments, Growth Rate, Revenue, and Forecast to 2029January 31, 2023 | marketwatch.comPeptide Therapy Industry by 360 Market Updates with, New Companies, Major Strategies, Massive Strategies And Forecast 2028January 30, 2023 | marketwatch.comWhy Lipella Pharmaceuticals Stock Is Soaring TodayJanuary 13, 2023 | benzinga.comMedexus sees over a year's delay for medac to provide data requested by FDA for treosulfanJanuary 12, 2023 | msn.comRare Disease Drug Market: The Adoption to Innovative Industry, Track Emerging Trends with Scoop on Economic ForcesJanuary 12, 2023 | marketwatch.comPharmaceutical Testing Market 2023 Report Focuses on Top Companys Research Methodology, Drivers and Opportunities | 108 Pages ReportJanuary 12, 2023 | marketwatch.comAnti-Counterfeit Pharmaceuticals And Cosmetics Forecast for 2028, Market 2023, Global Industry Trends, Share, Size, Growth, Analysis, DemandJanuary 11, 2023 | marketwatch.comPet Pharmaceuticals Market 2023 : Business Scenario, Corporate Profiles, Size and Dynamic Innovation by 2028January 11, 2023 | marketwatch.comAntiplatelet Drugs Market 2023 Expected to Witness the Highest Revenue Growth Over Forecast to 2028January 10, 2023 | marketwatch.comContract Research Organization (CRO) and CDMO for Pharmaceutical Market 2023 Expected to Reach Significant Rate by 2029January 10, 2023 | marketwatch.comOxaprozin Active Pharmaceutical Ingredients Market (New Report) to Eyewitness Massive Growth 2023 to 2028 | 104 Pages ReportJanuary 10, 2023 | marketwatch.comDiaphragm Valves for Pharmaceutical Process Market Size in 2023 | Growth Analysis, Key Players, Share, Revenue, Trends | Regional Forecast till 2028January 10, 2023 | marketwatch.com Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for PDDPF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PDDPF Media Mentions By Week PDDPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PDDPF News Sentiment▼0.000.39▲Average Medical News Sentiment PDDPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PDDPF Articles This Week▼00▲PDDPF Articles Average Week Get the Latest News and Ratings for PDDPF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ABSCF News Today LBTSF News Today AZFL News Today AVTBF News Today AVCNF News Today BIOYF News Today NUGS News Today CASBF News Today CNTMF News Today CBDL News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PDDPF) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
